 |
 Previous Article | Next Article 
Volume 16, Number 12,
Issue of June 15, 1996
pp. 3798-3806
Copyright ©1996 Society for Neuroscience
Determinants of Competitive Antagonist Sensitivity on Neuronal
Nicotinic Receptor  Subunits
Received Nov. 6, 1995; revised Feb. 15, 1996; accepted April 2, 1996.
Scott C. Harvey and
Charles W. Luetje
Department of Molecular and Cellular Pharmacology, University of
Miami School of Medicine, Miami, Florida 33101
We constructed a series of chimeric and mutant neuronal nicotinic
acetylcholine receptor  subunits to map amino acid residues that
determine sensitivity to competitive antagonists. The 2 and 4
subunits form pharmacologically distinct receptors when expressed in
combination with the  3 subunit in Xenopus oocytes. At
equipotent acetylcholine concentrations, 32 is 56-fold more
sensitive to blockade by dihydro--erythroidine than is 34. The
32 combination is also sensitive to long-term blockade by
neuronal bungarotoxin, whereas 34 is not. Pharmacological
analysis of receptors formed by chimeric subunits reveals that
amino acid residues that determine both dihydro--erythroidine and
neuronal bungarotoxin sensitivity are located within several sequence
segments. The major determinant of sensitivity to both competitive
antagonists is located between residues 54 and 63. A minor determinant
of sensitivity to both antagonists lies between residues 1 and 54, whereas a minor determinant of NBT sensitivity lies between residues 74 and 80. Within region 54-63 of 2, mutant 2 subunits were used to
identify threonine 59 as a residue critical in determining competitive
antagonist sensitivity. Changing threonine 59 to lysine, as occurs in
4, causes a 9-fold decrease in dihydro--erythroidine sensitivity
and a 71-fold decrease in neuronal bungarotoxin sensitivity. Changing
polar threonine 59 to negatively charged aspartate causes a 2.5-fold
increase in neuronal bungarotoxin sensitivity and has no effect on
dihydro--erythroidine sensitivity.
Key words:
nicotinic receptor;
neuronal;
antagonists;
mutant;
chimera;
neuronal bungarotoxin;
dihydro--erythroidine
This article has been cited by other articles:
|
|
|
|
 
S. Seo, J. T. Henry, A. H. Lewis, N. Wang, and M. M. Levandoski
The Positive Allosteric Modulator Morantel Binds at Noncanonical Subunit Interfaces of Neuronal Nicotinic Acetylcholine Receptors
J. Neurosci.,
July 8, 2009;
29(27):
8734 - 8742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-Y. Wu, C. M. Smith, S. M. Sine, and M. M. Levandoski
Morantel Allosterically Enhances Channel Gating of Neuronal Nicotinic Acetylcholine {alpha}3{beta}2 Receptors
Mol. Pharmacol.,
August 1, 2008;
74(2):
466 - 475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Parikh, K. Man, M. W. Decker, and M. Sarter
Glutamatergic Contributions to Nicotinic Acetylcholine Receptor Agonist-Evoked Cholinergic Transients in the Prefrontal Cortex
J. Neurosci.,
April 2, 2008;
28(14):
3769 - 3780.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. M. Shao, W. Tan, J. Xiu, N. Puskar, C. Fonck, H. A. Lester, and J. L. Feldman
{alpha}4* Nicotinic Receptors in preBotzinger Complex Mediate Cholinergic/Nicotinic Modulation of Respiratory Rhythm
J. Neurosci.,
January 9, 2008;
28(2):
519 - 528.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. T. Young, L. M. Broad, R. Zwart, P. C. Astles, M. Bodkin, E. Sher, and N. S. Millar
Species Selectivity of a Nicotinic Acetylcholine Receptor Agonist Is Conferred by Two Adjacent Extracellular beta4 Amino Acids that Are Implicated in the Coupling of Binding to Channel Gating
Mol. Pharmacol.,
February 1, 2007;
71(2):
389 - 397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wu, Q. Liu, K. Yu, J. Hu, Y.-P. Kuo, M. Segerberg, P. A. St John, and R. J. Lukas
Roles of nicotinic acetylcholine receptor {beta} subunits in function of human {alpha}4-containing nicotinic receptors
J. Physiol.,
October 1, 2006;
576(1):
103 - 118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. R. Abdrakhmanova, M. I. Damaj, F. I. Carroll, and B. R. Martin
2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine Is a Novel Potent Competitive Antagonist of Human Neuronal {alpha}4beta2 nAChRs
Mol. Pharmacol.,
June 1, 2006;
69(6):
1945 - 1952.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Endo, Y. Yanagawa, K. Obata, and T. Isa
Nicotinic Acetylcholine Receptor Subtypes Involved in Facilitation of GABAergic Inhibition in Mouse Superficial Superior Colliculus
J Neurophysiol,
December 1, 2005;
94(6):
3893 - 3902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Azam, C. Dowell, M. Watkins, J. A. Stitzel, B. M. Olivera, and J. M. McIntosh
{alpha}-Conotoxin BuIA, a Novel Peptide from Conus bullatus, Distinguishes among Neuronal Nicotinic Acetylcholine Receptors
J. Biol. Chem.,
January 7, 2005;
280(1):
80 - 87.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Salminen, K. L. Murphy, J. M. McIntosh, J. Drago, M. J. Marks, A. C. Collins, and S. R. Grady
Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in Mice
Mol. Pharmacol.,
June 1, 2004;
65(6):
1526 - 1535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Boorman, M. Beato, P. J. Groot-Kormelink, S. D. Broadbent, and L. G. Sivilotti
The Effects of {beta}3 Subunit Incorporation on the Pharmacology and Single Channel Properties of Oocyte-expressed Human {alpha}3{beta}4 Neuronal Nicotinic Receptors
J. Biol. Chem.,
November 7, 2003;
278(45):
44033 - 44040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Lang, R. Burgstahler, W. Sippel, D. Irnich, B. Schlotter-Weigel, and P. Grafe
Characterization of Neuronal Nicotinic Acetylcholine Receptors in the Membrane of Unmyelinated Human C-Fiber Axons by In Vitro Studies
J Neurophysiol,
November 1, 2003;
90(5):
3295 - 3303.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Everhart, E. Reiller, A. Mirzoian, J. M. McIntosh, A. Malhotra, and C. W. Luetje
Identification of Residues That Confer {alpha}-Conotoxin-PnIA Sensitivity on the {alpha}3 Subunit of Neuronal Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther.,
August 1, 2003;
306(2):
664 - 670.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Wilkins Jr., V. P. Grinevich, J. T. Ayers, P. A. Crooks, and L. P. Dwoskin
N-n-Alkylnicotinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Interaction with alpha 4beta 2* and alpha 7* Neuronal Nicotinic Receptors
J. Pharmacol. Exp. Ther.,
January 1, 2003;
304(1):
400 - 410.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. McIntosh, C. Dowell, M. Watkins, J. E. Garrett, D. Yoshikami, and B. M. Olivera
alpha -Conotoxin GIC from Conus geographus, a Novel Peptide Antagonist of Nicotinic Acetylcholine Receptors
J. Biol. Chem.,
September 6, 2002;
277(37):
33610 - 33615.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Zhou, J. Ren, E. Brown, D. Schneider, Y. Caraballo-Lopez, and J. J. Galligan
Pharmacological Properties of Nicotinic Acetylcholine Receptors Expressed by Guinea Pig Small Intestinal Myenteric Neurons
J. Pharmacol. Exp. Ther.,
September 1, 2002;
302(3):
889 - 897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Avalos, M. J. Parker, F. N. Maddox, F. I. Carroll, and C. W. Luetje
Effects of Pyridine Ring Substitutions on Affinity, Efficacy, and Subtype Selectivity of Neuronal Nicotinic Receptor Agonist Epibatidine
J. Pharmacol. Exp. Ther.,
September 1, 2002;
302(3):
1246 - 1252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Dourado and P. B. Sargent
Properties of Nicotinic Receptors Underlying Renshaw Cell Excitation by alpha -Motor Neurons in Neonatal Rat Spinal Cord
J Neurophysiol,
June 1, 2002;
87(6):
3117 - 3125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ferreira Jr, N. Sahibzada, M. Shi, W. Panico, M. Niedringhaus, A. Wasserman, K. J. Kellar, J. Verbalis, and R. A. Gillis
CNS Site of Action and Brainstem Circuitry Responsible for the Intravenous Effects of Nicotine on Gastric Tone
J. Neurosci.,
April 1, 2002;
22(7):
2764 - 2779.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Parker, S. C. Harvey, and C. W. Luetje
Determinants of Agonist Binding Affinity on Neuronal Nicotinic Receptor beta Subunits
J. Pharmacol. Exp. Ther.,
October 1, 2001;
299(1):
385 - 391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. P. Dwoskin and P. A. Crooks
Competitive Neuronal Nicotinic Receptor Antagonists: A New Direction for Drug Discovery
J. Pharmacol. Exp. Ther.,
August 1, 2001;
298(2):
395 - 402.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Levandoski, Y. Lin, L. Moise, J. T. McLaughlin, E. Cooper, and E. Hawrot
Chimeric Analysis of a Neuronal Nicotinic Acetylcholine Receptor Reveals Amino Acids Conferring Sensitivity to alpha -Bungarotoxin
J. Biol. Chem.,
September 10, 1999;
274(37):
26113 - 26119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Marks, P. Whiteaker, J. Calcaterra, J. A. Stitzel, A. E. Bullock, S. R. Grady, M. R. Picciotto, J.-P. Changeux, and A. C. Collins
Two Pharmacologically Distinct Components of Nicotinic Receptor-Mediated Rubidium Efflux in Mouse Brain Require the beta 2 Subunit
J. Pharmacol. Exp. Ther.,
May 1, 1999;
289(2):
1090 - 1103.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. J. Parker, A. Beck, and C. W. Luetje
Neuronal Nicotinic Receptor beta 2 and beta 4 Subunits Confer Large Differences in Agonist Binding Affinity
Mol. Pharmacol.,
December 1, 1998;
54(6):
1132 - 1139.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. Kehoe and J. M. McIntosh
Two Distinct Nicotinic Receptors, One Pharmacologically Similar to the Vertebrate alpha 7-Containing Receptor, Mediate Cl Currents in Aplysia Neurons
J. Neurosci.,
October 15, 1998;
18(20):
8198 - 8213.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. W. Luetje, F. N. Maddox, and S. C. Harvey
Glycosylation within the Cysteine Loop and Six Residues Near Conserved Cys192/Cys193 Are Determinants of Neuronal Bungarotoxin Sensitivity on the Neuronal Nicotinic Receptor alpha 3 Subunit
Mol. Pharmacol.,
June 1, 1998;
53(6):
1112 - 1119.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
Y. Fu, S. G. Matta, T. J. James, and B. M. Sharp
Nicotine-Induced Norepinephrine Release in the Rat Amygdala and Hippocampus is Mediated through Brainstem Nicotinic Cholinergic Receptors
J. Pharmacol. Exp. Ther.,
March 1, 1998;
284(3):
1188 - 1196.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. A. Stauderman, L. S. Mahaffy, M. Akong, G. Veliçelebi, L. E. Chavez-Noriega, J. H. Crona, E. C. Johnson, K. J. Elliott, A. Gillespie, R. T. Reid, et al.
Characterization of Human Recombinant Neuronal Nicotinic Acetylcholine Receptor Subunit Combinations alpha 2beta 4, alpha 3beta 4 and alpha 4beta 4 Stably Expressed in HEK293 Cells
J. Pharmacol. Exp. Ther.,
February 1, 1998;
284(2):
777 - 789.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. C. Chiara and J. B. Cohen
Identification of Amino Acids Contributing to High and Low Affinity d-Tubocurarine Sites in the Torpedo Nicotinic Acetylcholine Receptor
J. Biol. Chem.,
December 26, 1997;
272(52):
32940 - 32950.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Bren and S. M. Sine
Identification of Residues in the Adult Nicotinic Acetylcholine Receptor That Confer Selectivity for Curariform Antagonists
J. Biol. Chem.,
December 5, 1997;
272(49):
30793 - 30798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Fenster, M. F. Rains, B. Noerager, M. W. Quick, and R. A. J. Lester
Influence of Subunit Composition on Desensitization of Neuronal Acetylcholine Receptors at Low Concentrations of Nicotine
J. Neurosci.,
August 1, 1997;
17(15):
5747 - 5759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Harvey, J. M. Mcintosh, G. E. Cartier, F. N. Maddox, and C. W. Luetje
Determinants of Specificity for alpha -Conotoxin MII on alpha 3beta 2 Neuronal Nicotinic Receptors
Mol. Pharmacol.,
February 1, 1997;
51(2):
336 - 342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Chavez-Noriega, J. H. Crona, M. S. Washburn, A. Urrutia, K. J. Elliott, and E. C. Johnson
Pharmacological Characterization of Recombinant Human Neuronal Nicotinic Acetylcholine Receptors halpha 2beta 2, halpha 2beta 4, halpha 3beta 2, halpha 3beta 4, halpha 4beta 2, halpha 4beta 4 and halpha 7 Expressed in Xenopus Oocytes
J. Pharmacol. Exp. Ther.,
January 1, 1997;
280(1):
346 - 356.
[Abstract]
[Full Text]
|
|
|
|
|
